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Available online 27 November 2014Several lines of evidence point to an important role
of Selenium (Se) and selenoproteins for bone growth,
development and turnover:(i) Kashin–Beck disease, a
Se-dependent endemic osteoarthritis, can be prevented by
Se supplementation (Sudre and Mathieu, 2001), (ii) Se or
selenoprotein deﬁciency is associated with growth retarda-
tion in rodents (McKenzie et al., 2002; Schweizer and
Schomburg, 2005), (iii) genetic inactivation of selenoprotein
P (Sepp) causes a strong growth impairment in Sepp-
knockout mice (Schomburg et al., 2003), and (iv) circulating
Se and SEPP levels are associated with markers of bone
turnover and bone mineral density (Hoeg et al., 2012). In
order to better deﬁne the role of Se and selenoproteins in
bone physiology, we have compared Sepp-wildtype, -het-
erozygous and -knockout mice together with SEPP-
transgenic mice (Renko et al., 2008). As selenoprotein
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utz.schomburg@charite.de (L. Schomburg).have shown sex-speciﬁc effects (Schomburg and Schweizer,
2009), both female and male mice were included in our
studies.
Se concentrations were determined by total reﬂection X-ray
ﬂuorescence, gene expression levels were analysed by qRT-PCR
and proteins were quantiﬁed by Western blot analysis. Bone Se
was exclusively associated with proteins but not with the
inorganic matrix. Upon reduced Sepp expression bone Se
decreased and was partially rescued by hepatic SEPP transgene
expression. Among the set of 24 murine selenoprotein genes, 22
were successfully detected by qRT-PCR with characteristic sex-
speciﬁc and Se status-dependent differences. Interestingly, the
alleged Sepp-receptor ApoER2 (Lrp8) (Olson et al., 2007) was
strongly expressed in bone and ApoER2 transcripts were up-
regulated in response to impaired Sepp expression indicating a
potential feedback loop controlling Se supply to bone in times
of Se deﬁciency (Fig. 1). When serum and bone were compared
between the different murine genotypes, Se concentrations
differed by up to 25-fold in serum but only up to 2.5-fold
in bone.
This ﬁnding supports the notion that bone belongs to the
preferentially supplied tissues within the hierarchy of
Se target organs. Our results highlight important sex-
speciﬁc differences in bone selenoprotein expression, indi-
cate a novel mechanism for preferential Se uptake in times
of Se deﬁciency and contribute to our understanding of the
consistent bone phenotype in subjects with SBP2 mutations.rticle under the CC BY-NC-ND license
Fig. 1 Novel regulatory feedback loop in Se-deﬁcient bone.
Mice with impaired selenoprotein (Sepp) expression secrete
reduced Sepp amounts into blood causing a systemic Se
deﬁciency and a decline of serum Se by a factor of 25. In
comparison, bone appears to be largely resistant to low serum
Se levels as bone Se concentrations decline in parallel only
2.5-fold. One reason for this prioritised supply with Se of bone
may constitute the dynamic up-regulation of the SePP-receptor
ApoER2 (Lrp8) and the potential SePP-receptor Lrp1 by 6.0- and
5.4-folds, respectively.
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